<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oncology Product Guide &#187; Brain Cancer</title>
	<atom:link href="http://www.oncologyproductguide.com/blog/tag/brain-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.oncologyproductguide.com/blog</link>
	<description>A comprehensive guide to oncology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:00:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Aggressive Brain Cancer Driven By Two Collaborating Genes, Study</title>
		<link>http://www.oncologyproductguide.com/blog/2009/12/30/aggressive-brain-cancer-driven-by-two-collaborating-genes-study/</link>
		<comments>http://www.oncologyproductguide.com/blog/2009/12/30/aggressive-brain-cancer-driven-by-two-collaborating-genes-study/#comments</comments>
		<pubDate>Wed, 30 Dec 2009 11:55:37 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Brain Cancer]]></category>
		<category><![CDATA[Columbia Initiative in Systems Biology]]></category>
		<category><![CDATA[Herbert Irving Comprehensive Cancer Center]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/?p=198</guid>
		<description><![CDATA[Researchers of Herbert Irving Comprehensive  Cancer Center and the Columbia Initiative in Systems Biology have discovered two genes that appear to work together as master switches to turn on hundreds of other genes that drive the most aggressive forms of brain cancer: they hope their findings will help develop new approaches to treat these [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/12/Herbert-Irving-Comprehensive-Cancer-Center.png"><img class="alignright size-full wp-image-199" style="margin: 5px" src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/12/Herbert-Irving-Comprehensive-Cancer-Center.png" border="0" alt="Herbert Irving Comprehensive Cancer Center" width="200" height="26" /></a>Researchers of Herbert Irving Comprehensive  Cancer Center and the Columbia Initiative in Systems Biology have discovered two genes that appear to work together as master switches to turn on hundreds of other genes that drive the most aggressive forms of brain cancer: they hope their findings will help develop new approaches to treat these incurable tumors. These are the findings of a study published in the advanced online issue of the journal <em>Nature</em>.</p>
<p>For the full story, <a href="http://www.medicalnewstoday.com/articles/174884.php" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2009/12/30/aggressive-brain-cancer-driven-by-two-collaborating-genes-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study shows Avastin can play critical role in treatment of brain cancer</title>
		<link>http://www.oncologyproductguide.com/blog/2009/09/23/study-shows-avastin-can-play-critical-role-in-treatment-of-brain-cancer/</link>
		<comments>http://www.oncologyproductguide.com/blog/2009/09/23/study-shows-avastin-can-play-critical-role-in-treatment-of-brain-cancer/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 04:21:37 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Brain Cancer]]></category>
		<category><![CDATA[Avastin]]></category>
		<category><![CDATA[cancer drug]]></category>
		<category><![CDATA[cancer tratment]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[glioblastoma]]></category>
		<category><![CDATA[irinotecan chemotherapy]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[Roche Holding]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/?p=142</guid>
		<description><![CDATA[Roche Holding AG said cancer drug Avastin could play an important role in improving the daily lives of patients with the most aggressive form of brain cancer. An analysis of the phase II BRAIN study of Avastin alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma demonstrated that the [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/09/Roche.png"><img class="alignright size-full wp-image-143" style="margin: 5px" src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/09/Roche.png" alt="Roche" width="200" height="94" /></a>Roche Holding AG said cancer drug Avastin could play an important role in improving the daily lives of patients with the most aggressive form of brain cancer. An analysis of the phase II BRAIN study of Avastin alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma demonstrated that the six months Avastin-based therapy improved patients’ chances of remaining alive without worsening their disease and had additional positive impact on patients.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2009/09/23/study-shows-avastin-can-play-critical-role-in-treatment-of-brain-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
